Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders.
about
Autism spectrum disorder in adults: diagnosis, management, and health services developmentIdentification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.Aripiprazole for treating irritability in children & adolescents with autism: A systematic reviewReversal of social deficits by subchronic oxytocin in two autism mouse models.Repetitive behavior profile and supersensitivity to amphetamine in the C58/J mouse model of autism.Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.ASD: Psychopharmacologic Treatments and Neurophysiologic Underpinnings.SLC6A3 coding variant Ala559Val found in two autism probands alters dopamine transporter function and trafficking.Background, clinical features and treatment of attention deficit hyperactivity disorder in children.An update on medication management of behavioral disorders in autism.The Co-Occurrence of Autism Spectrum Disorder in Children With ADHD.Treatment options for the management of pervasive developmental disorders.An update on the comorbidity of ADHD and ASD: a focus on clinical management.Psychiatric Hospitalization of Children With Autism or Intellectual Disability: Consensus Statements on Best PracticesSymptom Profile of ADHD in Youth With High-Functioning Autism Spectrum Disorder: A Comparative Study in Psychiatrically Referred Populations.Pharmacotherapy effectiveness for clinical subgroups among children and adolescents with early onset schizophrenia.ECHO Autism.The Comorbid Diagnosis of ASD and ADHD: Clinical and Neuropsychological Perspectives
P2860
Q26741443-A134E1B2-B1FB-491B-94F3-8E290D1B50A9Q26744037-3D764E39-FCB4-45C0-84CD-DD6D6D8FEB82Q26784199-F6AAFEA8-0927-4053-92EF-6DAAEA9AE775Q28394708-5D229DB3-7A36-423D-83FD-25BABAF18962Q30419621-AAD1DB7D-44A7-42CB-AFAF-E76131FE62F0Q34257043-0EFE7E39-9A9A-46AB-A292-D5EEAAD6012AQ34270618-E01781DD-24DA-4DD0-8D00-8EE808777D44Q35150201-581A7437-852D-435B-8998-026216151FABQ38122410-FCEEF2AB-3FBF-4F62-ACB4-556432E9FD41Q38184482-03096B65-039B-4EEC-8F20-0A251721F4BBQ38725586-AEB7912C-395A-43FD-B785-FEC5C250E570Q38808579-F84BF98F-C435-467C-82AE-5F91E614B7FBQ38916468-6921DF4D-18B4-4627-8563-1A0F27170971Q40704784-85FCC612-DFF6-4D69-A6CB-30B7B335698BQ42105195-E0ECB267-CE58-40FD-8790-98F1751F7C4CQ48333433-08F70D22-4523-4025-99A3-D22BE3518EF3Q50304310-A2917402-DE96-461C-A600-24FE597994E1Q57566528-4B3F4231-EDFD-4798-A9F1-9DC6C55EA95D
P2860
Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Clinical practice pathways for ...... in autism spectrum disorders.
@en
type
label
Clinical practice pathways for ...... in autism spectrum disorders.
@en
prefLabel
Clinical practice pathways for ...... in autism spectrum disorders.
@en
P2093
P50
P921
P356
P1433
P1476
Clinical practice pathways for ...... in autism spectrum disorders.
@en
P2093
Agnes Whitaker
Antonio Hardan
Autism Speaks Autism Treatment Network Psychopharmacology Committee
Benjamin Handen
Maria Pilar Bernal
Rajneesh Mahajan
Rebecca Panzer
P304
P356
10.1542/PEDS.2012-0900J
P407
P478
130 Suppl 2
P577
2012-11-01T00:00:00Z